- Report
- May 2024
- 126 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- December 2023
- 140 Pages
Global
From €3897EUR$4,450USD£3,383GBP
- Report
- November 2024
- 159 Pages
Global
From €2190EUR$2,500USD£1,900GBP
- Report
- July 2024
- 166 Pages
Global
From €2190EUR$2,500USD£1,900GBP
- Report
- May 2024
- 176 Pages
Global
From €2190EUR$2,500USD£1,900GBP
- Report
- July 2021
- 151 Pages
Europe
From €3022EUR$3,450USD£2,623GBP
- Report
- December 2024
- 120 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- April 2024
- 134 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- January 2024
- 140 Pages
Global
From €3722EUR$4,250USD£3,231GBP
- Report
- September 2023
- 143 Pages
Global
From €3897EUR$4,450USD£3,383GBP
- Report
- December 2024
- 150 Pages
Global
From €3372EUR$3,850USD£2,927GBP
€4248EUR$4,850USD£3,687GBP
- Report
- November 2024
- 150 Pages
Global
From €3372EUR$3,850USD£2,927GBP
€4248EUR$4,850USD£3,687GBP
- Report
- September 2024
- 150 Pages
Global
From €3372EUR$3,850USD£2,927GBP
€4248EUR$4,850USD£3,687GBP
- Report
- August 2022
- 96 Pages
Global
From €4375EUR$4,995USD£3,797GBP
- Report
- January 2025
- 220 Pages
Global
From €4375EUR$4,995USD£3,797GBP
- Report
- August 2024
- 170 Pages
Global
From €4375EUR$4,995USD£3,797GBP
- Report
- January 2024
- 183 Pages
Global
€4375EUR$4,995USD£3,797GBP
- Report
- January 2024
- 276 Pages
Global
€4375EUR$4,995USD£3,797GBP
- Report
- January 2024
- 249 Pages
Global
€4375EUR$4,995USD£3,797GBP
- Report
- September 2023
- 270 Pages
Global
€4200EUR$4,795USD£3,645GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more